Recombinant human antithrombotic protein (Changzhou Qianhong Bio-pharma)
重组人抗血栓蛋白（常州千红生化制药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human antithrombotic protein (Changzhou Qianhong Bio-pharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangzhou Qianhong Biopharma Co LtdNanjing University
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesNanjing UniversityChangzhou Qianhong Biopharma Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A